|
San Diego, CA - December 17, 2002
LA
JOLLA PHARMACEUTICAL COMPLETES PHASE
III CLINICAL TRIAL
San Diego, CA - November 4, 2002
LA
JOLLA PHARMACEUTICAL COMPANY
REPORTS THIRD QUARTER 2002 FINANCIAL
RESULTS
San Diego, CA - October 27, 2002
LA
JOLLA PHARMACEUTICAL ANNOUNCES RESULTS
OF PHASE I/II TRIAL IN ANTIBODY-MEDIATED
THROMBOSIS PATIENTS AT ACR
San Diego, CA - October 24, 2002
LA
JOLLA PHARMACEUTICAL TO PRESENT AT MORGAN
KEEGAN EQUITY CONFERENCE
San Diego, CA - October 23, 2002
LA
JOLLA PHARMACEUTICAL ANNOUNCES ADDITIONS
TO SENIOR MANAGEMENT
San Diego, CA - October 22, 2002
LA
JOLLA PHARMACEUTICAL TO COMPLETE ENROLLMENT
OF PHASE III LUPUS CLINICAL TRIAL
San Diego, CA - October 7, 2002
LA
JOLLA PHARMACEUTICAL TO PRESENT AT UBS
WARBURG CONFERENCE
San Diego, CA - October 3, 2002
LA
JOLLA PHARMACEUTICAL PRESENTS AT 10TH
INTERNATIONAL CONGRESS ON ANTIPHOSPHOLIPID
ANTIBODIES
San Diego, CA - September 5, 2002
LA
JOLLA PHARMACEUTICAL PRESENTS AT BIOCENTURY
NEWSMAKERS CONFERENCE
San Diego, CA - August 6, 2002
LA
JOLLA PHARMACEUTICAL COMPANY
REPORTS SECOND QUARTER 2002 FINANCIAL
RESULTS
San Diego, CA - July 1, 2002
LA
JOLLA PHARMACEUTICAL SCIENTISTS PRESENT
AT FEDERATION OF CLINICAL IMMUNOLOGY
SOCIETIES
ANNUAL MEETING
San Diego, CA - June 11, 2002
LUPUS,
PSORIASIS AND ARTHRITIS FOUNDATION LEADERS
AND BIOTECHNOLOGY INDUSTRY DISCUSS WAYS
TO INCREASE CLINICAL TRIAL ENROLLMENT
AT BIO 2002
San Diego, CA - June 3, 2002
LA
JOLLA PHARMACEUTICAL APPOINTS DR. KEN
HEILBRUNN VICE PRESIDENT OF CLINICAL
DEVELOPMENT
San Diego, CA - May 22, 2002
LA
JOLLA PHARMACEUTICAL PRESENTS AT NEEDHAM
& COMPANY BIOTECHNOLOGY CONFERENCE
San Diego, CA - May 7, 2002
LA
JOLLA PHARMACEUTICAL COMPANY
REPORTS FIRST QUARTER 2002 FINANCIAL
RESULTS
San Diego, CA - April 25, 2002
LA
JOLLA PHARMACEUTICAL REPORTS NEW DATA
AT TUTZING MEDICAL CONFERENCE ON ANTIBODY-MEDIATED
THROMBOSIS
San Diego, CA - February 26, 2002
LA
JOLLA PHARMACEUTICAL COMPANY
REPORTS FOURTH QUARTER 2001 FINANCIAL
RESULTS
San Diego, CA - February 25, 2002
LA
JOLLA PHARMACEUTICAL SCIENTISTS PRESENT
AT TWO INTERNATIONAL AUTOIMMUNE DISEASE
MEDICAL CONFERENCES
San Francisco, CA -February 19, 2002
LA
JOLLA PHARMACEUTICAL TO PRESENT AT BIO
CEO & INVESTOR CONFERENCE
San Diego, CA - January 22, 2002
LA
JOLLA PHARMACEUTICAL ADDS VICE PRESIDENT
OF MANUFACTURING
San Diego, CA - January 15, 2002
LA
JOLLA PHARMACEUTICAL COMPANY ANNOUNCES
$51.6 MILLION PRIVATE PLACEMENT
Bethesda, MD - January 10, 2002
IMPACT
OF LA JOLLA PHARMACEUTICAL'S LUPUS
DRUG CANDIDATE ON PATIENTS' HEALTH-RELATED
QUALITY OF LIFE PRESENTED AT NIH CONFERENCE
San Francisco, CA - January 9, 2002
LA
JOLLA PHARMACEUTICAL DISCUSSES PROGRESS
AT
J.P. MORGAN H&Q CONFERENCE
|